President Trump Approves Gilead’s Remdesivir Drug for Coronavirus Patients

By our editor

President Donald Trump Friday announced Gilead’s antiviral drug, remdesivir has been approved by the United States regulators for emergency use on Coronavirus patients.

US medical officials have announced evidence from a trial that remdesivir helped patients with serious cases of COVID-19 recover faster.

Trump has been a vocal supporter of remdesivir as a possible way to bring the novel coronavirus pandemic under control. Nearly 65,000 Americans have died in the global crisis.

The media had reported that the coronavirus patients on the antiviral remdesivir recovered more than 30 per cent faster than those on a placebo, the results of a major clinical trial showed Wednesday as a top US scientist hailed the drug’s “clear-cut” benefit.

It represents the first time any medication has been shown to improve outcomes against the coronavirus illness, which has claimed more than 200,000 lives globally and brought the world economy to a grinding halt.